Mei‐Ling Nan
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral Infections and Vectors
- Immunology top 10%
- interferon and immune responses
Papers in
-
- interferon and immune responses 6
-
- Inflammasome and immune disorders 4
- RNA regulation and disease 1
- Co-authors
- Pei‐Hui Wang (6 shared papers)Chengjiang Gao (5 shared papers)Yi Zheng (5 shared papers)Lulu Han (5 shared papers)Jian Deng (5 shared papers)Meng‐Wei Zhuang (3 shared papers)Xuejing Zhang (1 shared paper)Jing Zhang (1 shared paper)
- Journals
- Journal of Medical Virology (4 papers)Signal Transduction and Targeted Therapy (1 paper)Advances in experimental medicine and biology (1 paper)
- Partner nations
- ChinaUnited StatesPortugal
In The Last Decade
Mei‐Ling Nan
6 papers receiving 451 citations
Peers
Comparison fields: 5 of 54
- Infectious Diseases 285
- Immunology 246
- Neurology 56
- Animal Science and Zoology 30
- Molecular Biology 180
Countries citing papers authored by Mei‐Ling Nan
This map shows the geographic impact of Mei‐Ling Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Ling Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Ling Nan more than expected).
Fields of papers citing papers by Mei‐Ling Nan
This network shows the impact of papers produced by Mei‐Ling Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Ling Nan. The network helps show where Mei‐Ling Nan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mei‐Ling Nan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 182 | |
| 2 | 2022 | 119 | |
| 3 | 2022 | 66 | |
| 4 | 2019 | 42 | |
| 5 | 2023 | 25 | |
| 6 | 2023 | 20 |
About Mei‐Ling Nan
Mei‐Ling Nan is a scholar working on Immunology, Molecular Biology, Infectious Diseases, Oncology and Epidemiology, having authored 6 papers that have together received 454 indexed citations. Recurring topics across this work include interferon and immune responses (6 papers), Inflammasome and immune disorders (4 papers), Cytokine Signaling Pathways and Interactions (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper), Viral Infections and Vectors (1 paper), RNA regulation and disease (1 paper) and Autophagy in Disease and Therapy (1 paper). The work is most often cited by research in Infectious Diseases (285 citations), Immunology (246 citations), Neurology (56 citations), Animal Science and Zoology (30 citations) and Molecular Biology (180 citations). Mei‐Ling Nan has collaborated with scholars based in China, United States and Portugal. Frequent co-authors include Pei‐Hui Wang, Chengjiang Gao, Yi Zheng, Lulu Han, Jian Deng, Meng‐Wei Zhuang, Xuejing Zhang, Jing Zhang, Yang Xiao and Jing Zhang. Their work appears in journals such as Journal of Medical Virology, Signal Transduction and Targeted Therapy and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.